Lack of a genetic risk continuum between pubertal timing in the general population and idiopathic hypogonadotropic hypogonadism.
delayed puberty
genetics
idiopathic hypogonadotropic hypogonadism
puberty
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
revised:
23
08
2024
received:
21
03
2024
accepted:
27
08
2024
medline:
11
9
2024
pubmed:
11
9
2024
entrez:
10
9
2024
Statut:
aheadofprint
Résumé
Pubertal timing is a highly heritable trait in the general population. Recently, a large-scale exome-wide association study has implicated rare variants in six genes (KDM4C, MC3R, MKRN3, PDE10A, TACR3, and ZNF483) as genetic determinants of pubertal timing within the general population. Two of the genes (TACR3, MKRN3) are already implicated in extreme disorders of pubertal timing. This observation suggests that there may be a pervasive "genetic risk continuum" wherein genes that govern pubertal timing in the general population, by extension, may also be causal for rare Mendelian disorders of pubertal timing. Hence, we hypothesized that the four novel genes linked to pubertal timing in the population will also contribute to idiopathic hypogonadotropic hypogonadism (IHH), a genetic disorder characterized by absent puberty. Exome sequencing data from 1322 unrelated IHH probands were reviewed for rare sequence variants (RSVs) (minor allele frequency bins: <1%; <0.1%; <0.01%) in the six genes linked to puberty in the general population. A gene-based rare variant association testing (RVAT) was performed between the IHH cohort and a reference public genomic sequences repository-the Genome Aggregation Database (gnomAD). As expected, RVAT analysis showed that RSVs in TACR3, a known IHH gene, were significantly enriched in the IHH cohort compared to gnomAD cohort across all three MAF bins. However, RVAT analysis of the remaining five genes failed to show any RSV enrichment in the IHH cohort across all MAF bins. Our findings argue strongly against a pervasive genetic risk continuum between pubertal timing in the general population and extreme pubertal phenotypes. The biologic basis of such distinct genetic architectures' merits further evaluation.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13445Subventions
Organisme : National Institute of Child Health and Human Development
ID : F32HD108873
Organisme : National Institute of Child Health and Human Development
ID : K23HD097296
Organisme : National Institute of Child Health and Human Development
ID : P50HD104224
Organisme : National Institute of Child Health and Human Development
ID : R01HD096324
Organisme : National Institute of Child Health and Human Development
ID : R37HD043341
Organisme : NIDCR NIH HHS
ID : R01DE031452
Pays : United States
Informations de copyright
© 2024 British Society for Neuroendocrinology.
Références
Hindy G, Dornbos P, Chaffin MD, et al. Rare coding variants in 35 genes associate with circulating lipid levels—a multi‐ancestry analysis of 170,000 exomes. Am J Hum Genet. 2022;109:81‐96.
Day FR, Thompson DJ, Helgason H, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017;49:834‐841.
Lunetta KL, Day FR, Sulem P, et al. Rare coding variants and X‐linked loci associated with age at menarche. Nat Commun. 2015;6:7756.
Kentistou KA, Kaisinger LR, Stankovic S, et al. Understanding the genetic complexity of puberty timing across the allele frequency spectrum. Nat Genet. 2024;56(7):1397‐1411.
Dwyer AA, Stamou MI, Anghel E, et al. Reproductive phenotypes and genotypes in men with IHH. J Clin Endocrinol Metab. 2023;108:897‐908.
Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467‐2475.
Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet. 2009;41:354‐358.
Gianetti E, Tusset C, Noel SD, et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin‐releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab. 2010;95:2857‐2867.
Sidhoum VF, Chan YM, Lippincott MF, et al. Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. J Clin Endocrinol Metab. 2014;99:861‐870.
Balasubramanian R, Crowley WF Jr. Isolated GnRH deficiency: a disease model serving as a unique prism into the systems biology of the GnRH neuronal network. Mol Cell Endocrinol. 2011;346:4‐12.
Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L. Smell identification ability: changes with age. Science. 1984;226:1441‐1443.
Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 1989;45:381‐384.
Davis EE, Balasubramanian R, Kupchinsky ZA, et al. TCF12 haploinsufficiency causes autosomal dominant Kallmann syndrome and reveals network‐level interactions between causal loci. Hum Mol Genet. 2020;29:2435‐2450.
McLaren W, Gil L, Hunt SE, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.
Hunt SE, Moore B, Amode RM, et al. Annotating and prioritizing genomic variants using the Ensembl Variant Effect Predictor—a tutorial. Hum Mutat. 2022;43:986‐997.
Fu JM, Satterstrom FK, Peng M, et al. Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet. 2022;54:1320‐1331.
Guo MH, Dauber A, Lippincott MF, Chan YM, Salem RM, Hirschhorn JN. Determinants of power in gene‐based burden testing for monogenic disorders. Am J Hum Genet. 2016;99:527‐539.
Morales J, Pujar S, Loveland JE, et al. A joint NCBI and EMBL‐EBI transcript set for clinical genomics and research. Nature. 2022;604:310‐315.
Van der Auwera GA, O'Connor BD, Safari aORMC. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. 1st ed. O'Reilly Media; 2020.
Oved JH, Lambert MP, Kowalska MA, Poncz M, Karczewski KJ. Population based frequency of naturally occurring loss‐of‐function variants in genes associated with platelet disorders. J Thromb Haemost. 2021;19:248‐254.
Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab. 2001;86:2364‐2368.
Chan YM, Lippincott MF, Sales Barroso P, et al. Using Kisspeptin to predict pubertal outcomes for youth with pubertal delay. J Clin Endocrinol Metab. 2020;105:e2717‐e2725.
Bomba L, Walter K, Soranzo N. The impact of rare and low‐frequency genetic variants in common disease. Genome Biol. 2017;18:77.
Zhu J, Choa RE, Guo MH, et al. A shared genetic basis for self‐limited delayed puberty and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2015;100:E646‐E654.
Cassatella D, Howard SR, Acierno JS, et al. Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures. Eur J Endocrinol. 2018;178:377‐388.
Howard SR, Guasti L, Poliandri A, et al. Contributions of function‐altering variants in genes implicated in pubertal timing and body mass for self‐limited delayed puberty. J Clin Endocrinol Metab. 2018;103:649‐659.
Zouaghi Y, Alpern D, Gardeux V, et al. Transcriptomic profiling of murine GnRH neurons reveals developmental trajectories linked to human reproduction. bioRxiv. 2023. https://doi.org/10.1101/2023.06.22.546062
Gardner EJ, Neville MDC, Samocha KE, et al. Reduced reproductive success is associated with selective constraint on human genes. Nature. 2022;603:858‐863.
Layman LC, Peak DB, Xie J, Sohn SH, Reindollar RH, Gray MR. Mutation analysis of the gonadotropin‐releasing hormone receptor gene in idiopathic hypogonadotropic hypogonadism. Fertil Steril. 1997;68:1079‐1085.
Sykiotis GP, Hoang XH, Avbelj M, et al. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010;95:3019‐3027.
Lippincott MF, Schafer EC, Hindman AA, et al. Contributions of common genetic variants to constitutional delay of puberty and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2024. https://doi.org/10.1210/clinem/dgae166